Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma
P53 and ATM are central checkpoint genes involved in the repair of DNA damage after ionising irradiation, which has been associated with risk of brain tumours. Therefore, we tested the hypothesis that polymorphisms and haplotypes in p53 and ATM could be associated with glioma and meningioma risk.
Material and Methods
Six hundred and eighty glioma cases (298 glioblastoma (GBM)), 503 meningioma cases, and 1555 controls recruited in the Nordic-UK Interphone study, were analysed in association with three polymorphisms in p53 (rs2287499, rs1042533, rs1625895) and five polymorphisms in ATM ( rs228599, rs3092992, rs664143, rs170548, rs3092993). Haplotypes were constructed using the HAPLOSTAT program.
The global statistical test of glioblastoma and p53 haplotypes was p = 0.02. The haplotype analysis on glioblastoma revealed the 1-2-2 haplotype (promotor-codon72-intron 6) had a frequency of 6.1% in cases compared with 9.8% in controls (p = 0.003).The 1-2-1 haplotype was significantly more frequent in GBM cases, 10.2%, than in controls, 7.3% (p = 0.02). The haplotype analysis in ATM revealed an increased frequency of the 1-1-1-2-1 haplotype in meningioma cases (33.8%) compared with controls (30.3%) (p = 0.03). The 2-1-2-1-1 haplotype had a lower frequency in meningioma cases (36.1%) than controls (40.7%) (p = 0.009).
This study found both positive and negative associations of haplotypes in p53 for glioblastoma and ATM for meningioma. This study provides new data that could add to our understanding of brain tumour susceptibility.
KeywordsBrain tumour Cell cycle control Etiology
- 11.Wrensch M, Kelsey K, Liu M et al (2005) ERCC1 and ERCC2 polymorphisms and adult glioma. Neurooncology 7:495–507Google Scholar
- 16.Cardis E, Kilkenny M (1999) International case-control study of adult brain, head and neck tumours: results oradiat. Protect Dosimetry 83:179–183Google Scholar
- 18.Lindstrom S, Wiklund F, Jonsson BA, Adami HO, Balter K, Brookes AJ, Xu J, Zheng SL, Isaacs WB, Adolfsson J, Gronberg H (2005) Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. Hum Genet 118(3–4):339–347PubMedCrossRefGoogle Scholar
- 20.Besag Clifford JP, (1991) Sequential Monte Carlo p-values. Biometrika 78:301–304Google Scholar
- 24.Biros E, Kalina I, Kohut A et al (2002) Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients. Biros Physiol Res 51:59–64Google Scholar
- 25.Wu X, Zhao H, Amos CI et al (2002) p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. Natl Cancer Inst 1;94:681–690Google Scholar
- 26.Storey A, Thomas M, Kalita A et al (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 21;393:229–234Google Scholar